Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity

Cancer Cell. 2023 Jun 12;41(6):1118-1133.e12. doi: 10.1016/j.ccell.2023.05.005. Epub 2023 Jun 1.

Abstract

Cyclic GMP-AMP synthase (cGAS) is the major sensor for cytosolic DNA and activates type I interferon signaling and plays an essential role in antitumor immunity. However, it remains unclear whether the cGAS-mediated antitumor activity is affected by nutrient status. Here, our study reports that methionine deprivation enhances cGAS activity by blocking its methylation, which is catalyzed by methyltransferase SUV39H1. We further show that methylation enhances the chromatin sequestration of cGAS in a UHRF1-dependent manner. Blocking cGAS methylation enhances cGAS-mediated antitumor immunity and suppresses colorectal tumorigenesis. Clinically, cGAS methylation in human cancers correlates with poor prognosis. Thus, our results indicate that nutrient stress promotes cGAS activation via reversible methylation, and suggest a potential therapeutic strategy for targeting cGAS methylation in cancer treatment.

Keywords: SUV39H1; antitumor immunity; cGAS; methionine; methylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CCAAT-Enhancer-Binding Proteins / genetics
  • Chromatin* / genetics
  • DNA
  • Demethylation
  • Humans
  • Immunity, Innate
  • Methionine* / genetics
  • Nucleotidyltransferases / genetics
  • Nucleotidyltransferases / metabolism
  • Ubiquitin-Protein Ligases / genetics

Substances

  • Chromatin
  • Methionine
  • Nucleotidyltransferases
  • DNA
  • UHRF1 protein, human
  • CCAAT-Enhancer-Binding Proteins
  • Ubiquitin-Protein Ligases